Personal care major Johnson & Johnson is working with biotech specialist Sequential Skin to investigate whether there are any new markers for skin health, particularly those linked to acne and ageing.
Personal care major Johnson & Johnson (J&J) has reported a net profit dip for the full year and last quarter of 2022 amidst ongoing macroeconomic challenges, though its CEO remains focused on heavy R&D investment.
Personal care major Johnson & Johnson (J&J) has reported a rise in third quarter (Q3) sales and a surge in net profit, bolstered by strong growth in pharma and med tech but also solid results across its global consumer health business.
Estonian beauty technology firm Haut.AI is aiming to expand its AI skin analysis tool in the Asian region, particularly in China, South Korea and Indonesia.
Johnson & Johnson (J&J) will become more competitive in personal care after the carve out of its consumer health business, particularly if it invests in personalised and premium NPD, an analyst says.
Personal care titan Johnson & Johnson (J&J) will split out its consumer health business to create a new publicly traded company, part of its wider plan to pursue more targeted growth strategies.
![J&J will combine its genomic database with data collected via Sequential Skin's skin patch tests to build out panels of skin health markers related to acne and ageing [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2023/03/15/johnson-johnson-sequential-skin-partnership-tracking-skin-health-markers-for-acne-and-ageing/16251070-1-eng-GB/Johnson-Johnson-Sequential-Skin-partnership-tracking-skin-health-markers-for-acne-and-ageing.jpg){kind=tracking}
![Johnson & Johnson remains on track to spin-off its consumer health division, featuring the Neutrogena brand among others [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/headlines/business-financial/johnson-johnson-2022-net-profit-dips-14-but-2023-guidance-remains-solid-albeit-prudent/16138406-1-eng-GB/Johnson-Johnson-2022-net-profit-dips-14-but-2023-guidance-remains-solid-albeit-prudent.jpg)
![Within J&J's consumer health business, its skin care brands Neutrogena and Aveena have performed strongly worldwide [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2022/10/20/johnson-johnson-q3-2022-net-profit-soars-21.6-with-worldwide-sales-up-and-guidance-maintained/15867791-1-eng-GB/Johnson-Johnson-Q3-2022-net-profit-soars-21.6-with-worldwide-sales-up-and-guidance-maintained.jpg)
![Haut.AI is aiming to expand its AI skin analysis tool in the Asian region. [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-asia.com/article/2022/04/27/ai-skin-analysis-firm-haut.ai-aiming-to-tap-into-tech-savvy-asian-market/15362115-1-eng-GB/AI-skin-analysis-firm-Haut.AI-aiming-to-tap-into-tech-savvy-Asian-market.jpg)
![Johnson & Johnson's decision to spin-off its consumer health unit will create space for dedicated R&D investment in personal care, benefitting consumers [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2021/11/22/johnson-johnson-consumer-health-company-to-become-premium-competitive-business-says-globaldata/13032125-1-eng-GB/Johnson-Johnson-Consumer-Health-Company-to-become-premium-competitive-business-says-GlobalData.jpg)
![Johnson & Johnson plans to complete the carve-out of a standalone Consumer Health business by the end of 2022 [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/headlines/business-financial/johnson-johnson-splits-consumer-health-business-to-drive-growth/13016725-1-eng-GB/Johnson-Johnson-splits-consumer-health-business-to-drive-growth.jpg)
